EUCTR2011-005243-28-GB进行中（未招募）1 期
A Phase 3bMulticenter, Open-label Abiraterone Acetate Long-term Safety Study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Currently participating in an abiraterone acetate clinical study considered complete and had received at least 3 months of treatment with abiraterone acetate tablets.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 117
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 183
排除标准
- •- Medical conditions that require hospitalization.
- •- Any condition or situation which, in the opinion of the investigator, may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient's participation in the study.
研究者
相似试验
进行中（未招募）
不适用
A Study Examining Long-term Access to Abiraterone AcetateMetastatic Castration-Resistant Prostate Cancer (PCR)MedDRA version: 14.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005243-28-ATJanssen-Cilag International NV300
进行中（未招募）
不适用
A Study Examining Long-term Access to Abiraterone AcetateEUCTR2011-005243-28-HUJanssen-Cilag International NV300
进行中（未招募）
1 期
A Study Examining Long-term Access to Abiraterone AcetateEUCTR2011-005243-28-ESJanssen-Cilag International NV31
进行中（未招募）
不适用
A Study that Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateMetastatic Castration-Resistant Prostate Cancer (PCR)MedDRA version: 14.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005243-28-DEJanssen-Cilag International NV300
进行中（未招募）
1 期
A Study that Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateEUCTR2011-005243-28-SEJanssen-Cilag International NV31